Article Information
History
- November 4, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anton Barchuk1,6,7,✉,
- Dmitriy Skougarevskiy1,
- Kirill Titaev1,
- Daniil Shirokov2,8,
- Yulia Raskina1,
- Anastasia Novkunkskaya1,
- Petr Talantov3,
- Artur Isaev5,
- Ekaterina Pomerantseva4,
- Svetlana Zhikrivetskaya4,
- Lubov Barabanova2 and
- Vadim Volkov1
- 1European University at St. Petersburg, Shpalernaya Ulitsa, 1, St. Petersburg, Russia, 191187
- 2Clinic “Scandinavia” (LLC Ava-Peter), Ilyushina Ulitsa, 4-1, St. Petersburg, Russia, 197372
- 3The Russian Academy of Sciences Commission for Counteracting the Falsification of Scientific Research, Leingradsky Prospekt, 14, Moscow, Russia, 119991
- 4Center of Genetics and Reproductive Medicine GENETICO LLC, Ulitsa Gubkina, 3-1, Moscow, Russia, 119333
- 5Human Stem Cells Institute, Ulitsa Gubkina, 3-2, Moscow, Russia, 119333
- 6N.N. Petrov National Research Medical Center of Oncology, Pesochny, Leningradskaya Ulitsa, 68, St. Petersburg, Russia, 197758
- 7Health Sciences, Faculty of Social Sciences, Tampere University, Arvo Ylpön katu 34, Tampere, Finland, 33520
- 8ITMO University, Kronverksky Prospekt, 49, St. Petersburg, Russia, 197101
- ↵✉Correspondence: abarchuk{at}eu.spb.ru
Posted November 04, 2020.
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
2
Blogs/Media
Author Videos